BCL2 and neoplasm: To reverse the MDR phenotype of tumor cells, we applied in our experiments two siRNAs: the bcl-2 siRNA targeted to bcl-2 mRNA and the mdr1b/1a siRNA targeted to mdr1b and mdr1a mRNAs.